The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Genetic Instability and Aberrant Dna Methylation in Chronic Hepatitis and Cirrhosis—A Comprehensive Study of Loss of Heterozygosity and Microsatellite Instability At 39 Loci and Dna Hypermethylation on 8 Cpg Islands in Microdissected Specimens From Patients With Hepatocellular Carcinoma
Abstract
A study was conducted to examine the significance of genetic instability and aberrant DNA methylation during hepatocarcinogenesis. Genomic DNA was extracted from 196 microdissected specimens of noncancerous liver tissue that showed no marked histologic findings or findings compatible with chronic hepatitis or cirrhosis, and 80 corresponding microdissected specimens of hepatocellular carcinoma (HCC) from 40 patients. Loss of heterozygosity (LOH) and microsatellite instability (MSI) were examined by polymerase chain reaction (PCR) using 39 microsatellite markers, and DNA methylation status on 8 CpG islands was examined by bisulfite–PCR. In noncancerous liver tissues, LOH, MSI, and DNA hypermethylation were found in 15 (38%), 6 (15%), and 33 (83%) of 40 cases, respectively. The incidence of DNA hypermethylation in histologically normal liver was similar to that in chronic hepatitis and cirrhosis, although neither LOH nor MSI was found in histologically normal liver. In cancerous tissues, LOH, MSI, and DNA hypermethylation were found in 39 (98%), 8 (20%), and 40 (100%) of 40 cases, respectively. CpG islands of the p16 gene and methylated in tumor 1, 2, 12, and 31 clones were frequently methylated in cancerous tissues, although neither the thrombospondin–1 nor the human Mut L homologue (hMLH1) gene was methylated. Absence of silencing of the hMLH1 gene by DNA hypermethylation is consistent with the low incidence of MSI in HCCs. The results of this study indicate that LOH and aberrant DNA methylation contribute to hepatocarcinogenesis; DNA hypermethylation in particular, which precedes or may even cause LOH, is as an early event during hepatocarcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
A second-generation linkage map of the human genome
Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., & Lathrop, M. (1992) · Nature · doi:10.1038/359794a0 · Cited by 1,685
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Xu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
COBRA: a sensitive and quantitative DNA methylation assay
Xiong, Z., & Laird, P. W. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2532 · Cited by 1,195
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
Nau, M. M., Brooks, B. J., Battey, J., Sausville, E., Gazdar, A. F., Kirsch, I. R., McBride, O. W., Bertness, V., Hollis, G. F., & Minna, J. D. (1985) · Nature · doi:10.1038/318069a0 · Cited by 665
Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.
Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T., & Hirohashi, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7416 · Cited by 645
Self-citationBrechot, C., Pourcel, C., Louise, A., Rain, B., & Tiollais, P. (1980) · Nature · doi:10.1038/286533a0 · Cited by 612
Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 530
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C.-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., & Johnson, P. J. (1999) · PubMed · Cited by 517
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., & Dryja, T. P. (1991) · PubMed · Cited by 466
Toyota, M., Ho, C., Ahuja, N., Jair, K. W., Li, Q., Ohe-Toyota, M., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 464
Reaction of sodium bisulfite with uracil, cytosine, and their derivatives
Hayatsu, H., Wataya, Y., Kai, K., & Iida, S. (1970) · Biochemistry · doi:10.1021/bi00816a016 · Cited by 347
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.
Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2403 · Cited by 335
Comprehensive allelotyping of human hepatocellular carcinoma
Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A., & Dejean, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201136 · Cited by 274
Sundaresan, V., Ganly, P. S., Hasleton, P. S., Rudd, R., Sinha, G., Bleehen, N. M., & Rabbitts, P. H. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90371-4 · Cited by 257
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
Kanai, Y., Ushijima, S., Hui, A.-M., Ochiai, A., Tsuda, H., Sakamoto, M., & Hirohashi, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<355::aid-ijc8>3.0.co;2-x · Cited by 253
Self-citationp16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma
Matsuda, Y., Ichida, T., Matsuzawa, J., Sugimura, K., & Asakura, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70137-x · Cited by 202
High frequency of p16INK4A gene alterations in hepatocellular carcinoma
Liew, C. T., Li, H.-M., Lo, K.-W., Leow, C. K., Chan, J. Y., Hin, L. Y., Lau, W. Y., Lai, P. B. S., Lim, B. K., Huang, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202359 · Cited by 180
Methylation and silencing of the Thrombospondin-1 promoter in human cancer
Li, Q., Ahuja, N., Burger, P. C., & Issa, J.-P. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202663 · Cited by 171
Tsuda, H., Hirohashi, S., Shimosato, Y., Terada, M., & Hasegawa, H. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80093-3 · Cited by 164
Self-citationMolecular genetic studies of early breast cancer evolution
O'Connell, P., Pekkel, V., Fuqua, S. A. W., Osborne, C. K., & Allred, D. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666201 · Cited by 118
Remus, R., Kämmer, C., Heller, H., Schmitz, B., Schell, G., & Doerfler, W. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1010-1022.1999 · Cited by 118
Kanai, Y., Hui, A., Sun, L., Ushijima, S., Sakamoto, M., Tsuda, H., & Hirohashi, S. (1999) · Hepatology · doi:10.1002/hep.510290338 · Cited by 111
Self-citationKanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., & Hirohashi, S. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00316-x · Cited by 108
Self-citationMakos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J. D., Isaacs, W. B., Linehan, W. M., & Baylin, S. B. (1993) · PubMed · Cited by 98
Sun, L., Hui, A., Kanai, Y., Sakamoto, M., & Hirohashi, S. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00345.x · Cited by 94
Self-citationHypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines
Almeida, A., Kokalj-Vokač, N., Lefrançois, D., Viégas-Pèquignot, E., Jeanpierre, M., Dutrillaux, B., & Malfoy, B. (1993) · Human Genetics · doi:10.1007/bf00205077 · Cited by 87
Aberrant DNA Methylation on Chromosome 16 Is an Early Event in Hepatocarcinogenesis
Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., Sugimura, T., & Hirohashi, S. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03135.x · Cited by 83
Self-citationKokalj-Vokač, N., Almeida, A., Viégas-Pèquignot, E., Jeanpierre, M., Malfoy, B., & Dutrillaux, B. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133492 · Cited by 82
DNA hypermethylation is associated with 17p allelic loss in neural tumors.
Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W. K., Brodeur, G. M., & Baylin, S. B. (1993) · PubMed · Cited by 75
Ikeda, M., Orimo, H., Moriyama, H., Nakajima, E., Matsubara, N., Mibu, R., Tanaka, N., Shimada, T., Kimura, A., & Shimizu, K. (1998) · PubMed · Cited by 67
Weiss, R. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602318 · Cited by 50
The Insertion of Foreign DNA Into Mammalian Genomes and Its Consequences: A Concept in Oncogenesis
Doerfler, W. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60259-6 · Cited by 47
Cited by
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
Berdasco, M., & Esteller, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.10.005 · Cited by 618
Poschl, G. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh057 · Cited by 442
Niwa, T., Tsukamoto, T., Toyoda, T., Mori, A., Tanaka, H., Maekita, T., Ichinose, M., Tatematsu, M., & Ushijima, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2755 · Cited by 417
Metadata
- Authors
- Kondo, Y., Kanai, Y., Sakamoto, M., Mizokami, M., Ueda, R., & Hirohashi, S.
- Venue
- Hepatology
- Published
- 2000-11
- Volume
- 32
- Issue
- 5
- Pages
- 970-979
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2085023377
- Cited by
- 273
- References
- 43
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.